Unit of epidemiology, institute of environmental medicine, Karolinska Institutet, Stockholm, Sweden.
Unit of cardiovascular epidemiology, institute of environmental medicine, Karolinska Institutet, Stockholm, Sweden.
Diabetes Metab. 2017 Dec;43(6):536-542. doi: 10.1016/j.diabet.2017.05.010. Epub 2017 Jun 29.
A family history of diabetes (FHD) is a strong predictor of diabetes risk, yet has rarely been investigated in latent autoimmune diabetes in adults (LADA). This study therefore investigated the risk of LADA and type 2 diabetes (T2D) in relation to FHD, taking into account the type of diabetes in relatives.
Data from a population-based study were used, including incident cases of LADA [glutamic acid decarboxylase antibody (GADA)-positive, n=378] and T2D (GADA-negative, n=1199), and their matched controls (n=1484). First-degree relatives with disease onset at age<40 years and taking insulin treatment were classified as type 1 diabetes (T1D) or, if otherwise, as T2D. Odds ratios (ORs) were adjusted for age, gender, BMI, education and smoking. Cases were genotyped for high- and low-risk HLA genotypes.
Both FHD-T1D (OR: 5.8; 95% CI: 3.2-10.3) and FHD-T2D (OR: 1.9; 95% CI: 1.5-2.5) were associated with an increased risk of LADA, whereas the risk of T2D was associated with FHD-T2D (OR: 2.7; 95% CI: 2.2-3.3), but not FHD-T1D. In LADA patients, FHD-T1D vs FHD-T2D was associated with higher GADA but lower C-peptide levels, lower prevalence of low-risk HLA genotypes (5.0% vs 28.6%, respectively; P=0.038) and a tendency for higher prevalence of high-risk genotypes (90.0% vs 69.1%, respectively; P=0.0576).
The risk of LADA is substantially increased with FHD-T1D but also, albeit significantly less so, with FHD-T2D. This supports the idea of LADA as a mix of both T1D and T2D, but suggests that the genes related to T1D have greater impact. LADA patients with FHD-T1D had more T1D-like features, emphasizing the heterogeneity of LADA.
家族糖尿病史(FHD)是糖尿病风险的一个强有力预测因素,但在成人隐匿性自身免疫性糖尿病(LADA)中很少被研究。因此,本研究调查了 FHD 与 LADA 和 2 型糖尿病(T2D)风险之间的关系,同时考虑了亲属中糖尿病的类型。
本研究使用了一项基于人群的研究数据,包括新发病例的 LADA[谷氨酸脱羧酶抗体(GADA)阳性,n=378]和 T2D(GADA 阴性,n=1199),以及他们的匹配对照者(n=1484)。年龄<40 岁且接受胰岛素治疗的一级亲属被归类为 1 型糖尿病(T1D),否则为 2 型糖尿病(T2D)。比值比(ORs)根据年龄、性别、BMI、教育程度和吸烟情况进行了调整。病例进行了高风险和低风险 HLA 基因型的基因分型。
FHD-T1D(OR:5.8;95%CI:3.2-10.3)和 FHD-T2D(OR:1.9;95%CI:1.5-2.5)均与 LADA 的发病风险增加相关,而 T2D 的发病风险与 FHD-T2D(OR:2.7;95%CI:2.2-3.3)相关,但与 FHD-T1D 无关。在 LADA 患者中,FHD-T1D 与 FHD-T2D 相比,GADA 水平更高,但 C 肽水平更低,低风险 HLA 基因型的患病率更低(分别为 5.0%和 28.6%;P=0.038),而高风险基因型的患病率有增高的趋势(分别为 90.0%和 69.1%;P=0.0576)。
FHD-T1D 与 LADA 的发病风险显著增加,而 FHD-T2D 与 LADA 的发病风险也显著增加。这支持了 LADA 既是 1 型糖尿病也是 2 型糖尿病的混合体的观点,但表明与 1 型糖尿病相关的基因具有更大的影响。FHD-T1D 的 LADA 患者具有更多的 1 型糖尿病特征,强调了 LADA 的异质性。